What we do Vivanta Industries Limited is engaged in project management consultancy and turnkey projects primarily for pharmaceuticals, agriculture, and prefabricated factories. |
Founded in 2,013 |
Market share Emerging player in project management and turnkey solutions within niche sectors. |
Problem solved Provides end-to-end project execution and consultancy addressing infrastructure needs in pharma and agro sectors. |
Top clients or who we serve Primarily B2B clients in pharmaceuticals, agriculture, and construction sectors. |
Key management Mr. Parikh H. A. (Managing Director, Promoter) with considerable leadership experience. |
Our journey and innovations Started as a trading firm in 2013; transitioned through amalgamations; pivoted to project consultancy and turnkey projects by 2023-24. |
Where we operate Primarily India with recent subsidiary expansion in local markets. |
Top products or what we offer Services include Project Management Consultancy and Turnkey Project Execution with technology supply. |
Top brands - |
Raw materials needed - |
Raw materials supplier - |
Recurring vs cyclical contribution Revenue primarily project-based and cyclical tied to project execution phases. |
Our industry position Growing company with expanding footprint in pharma and agro infrastructure project management. |
Financial highlights Revenue Rs. 110.37 Cr for FY 2024-25 with net loss of Rs. 1.32 Cr; showing 33.8% revenue growth year-on-year. |
Geographical revenue split - |
Order book - |
Whats driving growth Growth driven by expansion into turnkey projects, acquisition of subsidiary, and increased order volumes. |
Our future plans Focus on commercializing projects, further expanding turnkey projects and technological offerings. |
Our green promise - |
Our people and values Committed to ethical work culture, employee safety, and regulatory compliance. |
Key challenges ahead Profitability restoration, regulatory compliance, and competitive project bidding risks. |
Interesting facts Acquired Trinity Ganesh Private Limited as subsidiary in October 2024, strengthening business portfolio. |
Risks and strategy Risks include market competition and regulatory changes; mitigated via diversified offerings and strong internal controls. |
